Protalix Biotherapeutics Inc (PLX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
219,155,000
EV to revenue ratio (TTM)
2.408
EV to ebitda
7.39
Financial Performance
Revenue (TTM)
80,619,000
Gross profit (TTM)
36,898,000
EBITDA
24,860,000
Profitability
Operating margin (TTM)
23.50%
Profit margin
23.50%
Return on assets (TTM)
15.40%
Return on equity (TTM)
31.20%
Per Share Metrics
Revenue per share (TTM)
1.01
EPS
0.23
Diluted EPS (TTM)
0.23
Book value
0.89
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
11.83
Trailing P/E
11.83
Forward P/E
55.87
PEG ratio
-0.1
Price to sales ratio (TTM)
2.718
Price to book ratio (TTM)
3.159
Growth
Quarterly earnings growth (YoY)
27.10%
Quarterly revenue growth (YoY)
2,241.00%
Analyst Sentiment
Strong buy
0
Buy
1
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.02